胸腔积液,Pleural effusion
1)Pleural effusion胸腔积液
1.Systemic chemotherapy combined with intrathoracic sequent immunotherapy for patients with malignant pleural effusion due to non-small cell lung cancer (NSCLC);双路化疗免疫序贯治疗非小细胞肺癌胸腔积液
2.Pleural effusion caused by bronchial fluke;肺吸虫病引起的胸腔积液
英文短句/例句
1.Clinical application of medical thoracoscopy in unknown pleural effusion胸腔镜在不明原因胸腔积液中的应用
2.AiDi injection pleural infusion chemotherapy in the treatment of 52 malignancy patients with pleural effusion艾迪注射液胸腔内注射治疗恶性胸腔积液52例
3.(4) pleurorrhea and pleural thickening are most commonly seen in SLE .(4)胸腔积液、胸膜增厚以SLE最多见 ;
4.The Value of Pleural Biopsy in the Etiological Diagnosis of Pleural Effussion胸膜活检对胸腔积液的病因诊断价值
5.Intrapleural DDP in the Treatment of Malignant Pleural Effusions中剂量顺铂胸腔给药治疗癌性胸腔积液
6.Analysis of thoracoscopy in the pleural effusion of unknown reason胸腔镜检查诊断不明原因的胸腔积液临床分析
7.Value of indwelling catheter into intrathoracic cavity treated with tuberculous pleural effusion胸腔内置管治疗结核性胸腔积液的价值
8.Intracavitary administration of Arsenic Trioxide in treatment of lung cancer complicated with pleural effusion三氧化二砷胸腔内灌注治疗肺癌合并胸腔积液
9.Iodophor rinse treatment of intrathoracic tuberculous pleural effusion碘伏胸腔内冲洗治疗结核性胸腔积液疗效观察
10.Application of flexible t medical horacoscopy in the diagnosis of pleural effusion可弯曲内科胸腔镜诊断胸腔积液临床应用
11.Fine Catheter Thoracostomy Closed Drainage Versus Conventional Pleural Aspiration in the Treatment of Malignant Pleural Effusion微创置管胸腔引流与常规胸腔穿刺治疗恶性胸腔积液的效果观察
12.Diagnostic and therapeutical value of using multi-situs forceps cliping thoracoscopy for malignant pleural effusion经内科胸腔镜多部位胸膜钳夹对恶性胸腔积液的诊治价值
13.Diagnosis and therapy of malignant pleural effusion using multi-situs forceps cliping through thoracoscopy经内科胸腔镜多部位胸膜钳夹对恶性胸腔积液的诊疗作用
14.The Short-term Curative Effect of Pleural Effusion due to Lung Cancer treated with BCG-CSN斯奇康治疗肺癌胸腔积液的近期疗效
15.PLEURAL EFFUSION IN PATIENTS AGED OVER 50--An Analysis of 78 cases50岁以上胸腔积液患者78例分析
16.The Analysis of Pathogeny and Diagnostic Method on 558 Cases Pleural Effusion;胸腔积液558例病因及诊断方法分析
17.The Value of Detection of Survivin mRNA in Malignant Pleural Effusion;survivin基因在恶性胸腔积液诊断中的价值
18.Proteomic Analysis of Pleural Effusion from Lung Adenocarcinoma Patients by Shotgun Strategy;肺腺癌胸腔积液Shotgun蛋白质组学分析
相关短句/例句
hydrothorax[英][,haidr?"θ?ur?ks][美][,ha?dr?"θor?ks]胸腔积液
1.Mesothelial Cell,CEA,CK and Vimentin in Diagnosis of Hydrothorax:A Study of Clinical Value;间皮细胞、癌胚抗原、角蛋白、波型蛋白在胸腔积液临床诊断中的作用
2.Significance of Combinatory Detection of Hydrothorax ProgastrinReleasing Peptide and Carcino-embryonic Antigen in Diagnosisof Lung Cancer Complicated with Malignant Pleural Effusion;胸水ProGRP及CEA联合检测在肺癌并发恶性胸腔积液诊断中的价值
3.The Value of Ultrasonography in the Diagnosis of Hydrothorax;超声在胸腔积液中的诊断价值
3)Pleural effusions胸腔积液
parison of the diagnostic value of DNA analysis and CEA and SF level in benign and malignant pleural effusions;DNA倍体分析、癌胚抗原、铁蛋白对良恶性胸腔积液诊断价值的研究
2.Value of combined measurements of chromosome and adenosine deaminase (ADA) for identification of benign and malignant pleural effusions;联合检测染色体及腺苷脱氨酶对鉴别良恶性胸腔积液的价值
3.Expression of soluble interleukin 2 receptor and tumor necrosis factor in pleural effusions;可溶性白介素2受体与肿瘤坏死因子在胸腔积液中的表达
4)Pleural fluid胸腔积液
1.Expressions and significances of CEA and CA199 in pleural fluid of patients with lung adenocarcinoma;肺腺癌患者胸腔积液中CEA和CA199的表达及意义
2.\ Methods\ The levels of CEA, CYFRA 21 1 and NSE were detected both in serum and pleural fluid of patients with pleural effusion by means of immunoradiometric assay.①目的探讨测定癌胚抗原 (CEA)、非小细胞肺癌标志物 (CYFRA2 1 1)和神经元特异性烯醇化酶(NSE)对良恶性胸腔积液的鉴别诊断价值。
3.Objective: To investigate the effectives of Bleomycin and Interleukin II (IL-II) injected into thoracic cavity by central venous catheter (CVC) in the treatment of malignant pleural fluid.本研究在此基础上对40例恶性胸腔积液患者胸腔内随机注入博莱霉素与白细胞介素Ⅱ,旨在对两种药物的治疗效果进行对比研究。
5)Malignant pleural effusion胸腔积液
1.Clinical evaluation of radio-heating-chemotherapy in treatment of patients with malignant pleural effusion;射频透热联合化疗治疗恶性胸腔积液的临床评价
2.Objective To observe the therapeutic efficacy of intraplearal injection of kanserin in the treatment of malignant pleural effusion.目的探讨康赛宁腔内注射治疗恶性胸腔积液的临床疗效。
6)pleural effusion胸膜腔积液
1.Objective: To establish an animal model of inflammatorypleural effusion.目的 :建立一种炎性胸膜腔积液 (简称胸液 )的动物模型。
延伸阅读
胸腔积液胸腔积液pleuraleffusion由多种原因引起的胸膜腔内液体增多的现象。病因和发病机理健康人胸腔内液体不断地形成和吸收，处于动态平衡。从发病机理来看，胸腔积液产生于以下几种情况：①胸膜毛细血管内压力增高可形成漏出液，如充血性心力衰竭、缩窄性心包炎、上腔静脉阻塞。②胸膜毛细血管内胶体渗透压降低形成胸腔漏出液，如低蛋白血症、肝硬变、肾病综合征。③胸膜毛细血管壁通透性增加形成渗出性胸腔积液，如结核性胸膜炎、肺炎性胸膜炎、结缔组织病、肺癌、胸膜间皮瘤、肺梗塞等。④胸膜淋巴引流蛋白功能障碍引起渗出性胸腔积液，如癌肿引起淋巴管受阻。⑤胸膜腔内细菌感染形成渗出性胸膜炎或脓胸。⑥胸膜粘连因自发性气胸而撕裂，或主动脉瘤破裂以及外伤产生血胸。⑦胸导管破裂形成乳糜胸。临床表现由于原发疾病不同，积液的性质、数量和形成速度不同，以及基础肺功能状态不同，其临床症状不同。由于炎症引起的渗出性胸腔积液，当液体量较少（初期或吸收期）时可出现明显胸痛，尤其是深呼吸时明显。积液量少于200毫升者可无症状，中等量或大量积液时出现呼吸困难。积液形成速度较慢者呼吸困难不显著，短期内形成多量胸水者呼吸困难严重。原来肺功能较差的患者发生胸水时症状明显。此外患者还可表现出各种原发疾病的一些症状。胸腔积液患者体征主要与积液量多少有关。少量积液时可无阳性体征，或仅表现为患侧下胸部叩浊，呼吸音减弱。中等量积液时下胸部呼吸运动减弱，语颤减弱或消失，叩诊实音，呼吸音减弱或消失。同时心脏、气管、纵隔向健侧移位。大量积液时患侧胸廓饱满；呼吸运动减弱，语颤消失，叩诊实音，呼吸音消失。诊断首先应明确是否存在胸腔积液，其次是明确胸水的性质及引起胸腔积液的原发疾病。根据症状和体征通常可以诊断胸腔积液，但少量胸腔积液诊断比较困难，需要进行X射线检查和超声波检查。X射线检查可见肋膈角变钝。超声波检查不仅可以协助临床确定有无胸水、病变部位及胸水数量，并可以鉴别胸水和胸膜肥厚，此外还可以指导胸膜腔穿刺。根据胸水外观以及胸水常规可以初步判断是漏出性还是渗出性，还可以根据血清和胸水中蛋白含量以及乳酸脱氢酶含量判断是否为渗出性胸水。临床上胸水诊断中十分重要的另一个问题是如何鉴别良性（主要是结核性）和癌性胸水。目前认为比较有价值的方法包括胸水中腺苷脱氨酶水平测定，胸水细胞学检查、胸膜活检及淋巴结活检。治疗主要治疗原发疾病，积液量较多、压迫症状明显时，尤其是感染性胸腔积液应积极抽取胸水以减轻症状和防止胸膜粘连。
